ID
25901
Beskrivning
Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876
Länk
https://clinicaltrials.gov/ct2/show/NCT00291876
Nyckelord
Versioner (2)
- 8/23/17 8/23/17 -
- 9/26/17 9/26/17 -
Uppladdad den
September 26, 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION CONCOMITANT VACCINATION NCT00291876
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION CONCOMITANT VACCINATION NCT00291876
Beskrivning
CONCOMITANT VACCINATION
Beskrivning
Concomitant Vaccination
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0042196
- UMLS CUI [1,2]
- C2347852
Beskrivning
admnistration date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C1533734
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C0042210
Beskrivning
CONCOMITANT VACCINATION
Similar models
GSK Hepatitis A Vaccine ADDITIONAL VACCINATION CONCOMITANT VACCINATION NCT00291876
C0600091 (UMLS CUI [1,2])
C2347852 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0042210 (UMLS CUI [1,3])
Inga kommentarer